Evidence map›Paper›PMID 26444547›Full record

ArticlePloS one2015

Endothelium Expression of Bcl-2 Is Essential for Normal and Pathological Ocular Vascularization.

Ismail S Zaitoun, Ryan P Johnson, Nasim Jamali, Reem Almomani, Shoujian Wang, Nader Sheibani, Christine M Sorenson

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Contribution of cell death signaling to blood vessel formation.Cellular and molecular life sciences : CMLS · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Endothelial cell apoptosis in angiogenesis and vessel regression.Cellular and molecular life sciences : CMLS · 2017
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ismail S ZaitounDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI, 53705, United States of America.
Ryan P JohnsonDepartment of Pediatrics, University of Wisconsin, Madison, WI, 53705, United States of America.
Nasim JamaliDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI, 53705, United States of America; McPherson Eye Research Institute, University of Wisconsin, Madison, WI, 53705, United States of America.
Reem AlmomaniDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI, 53705, United States of America.
Shoujian WangDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI, 53705, United States of America.
Nader SheibaniDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI, 53705, United States of America; McPherson Eye Research Institute, University of Wisconsin, Madison, WI, 53705, United States of America.
Christine M SorensonDepartment of Pediatrics, University of Wisconsin, Madison, WI, 53705, United States of America; McPherson Eye Research Institute, University of Wisconsin, Madison, WI, 53705, United States of America.
University of Wisconsin–Madison · USSmith-Kettlewell Eye Research Institute · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Nihal Ahmad · 1985 to 2026
$142.6M
UW Vision Research Core - Administrative CoreP30EY016665 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI Donna M Peters · 2005 to 2026
$12.6M
Novel Antiangiogenic Peptides for Treatment of Exudative AMDR24EY022883 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI SHEIBANI, NADER · 2013 to 2017
$6.2M
Bcl-2 and ocular neovascularizationR21EY023024 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI SORENSON, CHRISTINE M · 2013 to 2014
$410k
NCI NIH HHS P30 CA014520NEI NIH HHS P30 EY016665NEI NIH HHS R21 EY023024NEI NIH HHS R21EY023024NEI NIH HHS R24 EY022883
6 · The paper itself

Abstract

Bcl-2 is an anti-apoptotic protein with important roles in vascular homeostasis and angiogenesis. Mice globally lacking Bcl-2 (Bcl-2 -/-) are small in stature and succumb to renal failure shortly after weaning as a result of renal hypoplasia/cystic dysplasia. We have shown that Bcl-2 -/- mice displayed attenuated retinal vascular development and neovascularization. In vitro studies indicated that in addition to modulating apoptosis, Bcl-2 expression also impacts endothelial and epithelial cell adhesion, migration and extracellular matrix production. However, studies delineating the cell autonomous role Bcl-2 expression plays in the endothelium during vascular development, pruning and remodeling, and neovascularization are lacking. Here we generated mice carrying a conditional Bcl-2 allele (Bcl-2Flox/Flox) and VE-cadherin-cre (Bcl-2EC mice). Bcl-2EC mice were of normal stature and lifespan and displayed some but not all of the retinal vascular defects previously observed in global Bcl-2 deficient mice. Bcl-2EC mice had decreased numbers of endothelial cells, decreased retinal arteries and premature primary branching of the retinal vasculature, but unlike the global knockout mice, spreading of the retinal superficial vascular layer proceeded normally. Choroidal neovascularization was attenuated in Bcl-2EC mice, although retinal neovascularization accompanying oxygen-induced ischemic retinopathy was not. Thus, Bcl-2 expression in the endothelium plays a significant role during postnatal retinal vascularization, and pathological choroidal but not retinal neovascularization, suggesting vascular bed specific Bcl-2 function in the endothelium.

Indexed as

AnimalsEndothelium, VascularEyeFemaleMiceNeovascularization, PathologicNeovascularization, PhysiologicProto-Oncogene Proteins c-bcl-2RetinaRetinal VesselsBcl2 protein, mouseProto-Oncogene Proteins c-bcl-2

Identifiers

PMID26444547
PMCPMC4622043
OpenAlexW2239114388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.